Skip to main content
Mesoblast Limited (ASX: MSB)
Australia flag Australia · Delayed Price · Currency is AUD
1.485
-0.090 (-5.71%)
Nov 21, 2024, 4:10 PM AEST

Mesoblast Revenue

In the fiscal year ending June 30, 2024, Mesoblast had annual revenue of $5.90M USD, down -21.32%. Mesoblast had revenue of $1.26M in the quarter ending June 30, 2024, a decrease of -41.23%.

Revenue
$5.90M
Revenue Growth
-21.32%
P/S Ratio
165.66
Revenue / Employee
$80.85K
Employees
73
Market Cap
1.69B AUD

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20245.90M-1.60M-21.32%
Jun 30, 20237.50M-2.71M-26.54%
Jun 30, 202210.21M2.78M37.36%
Jun 30, 20217.43M-24.72M-76.88%
Jun 30, 202032.16M15.43M92.30%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 22.18B
ResMed Inc. 6.93B
Pro Medicus Limited 161.50M
Fisher & Paykel Healthcare Corporation Limited 1.60B
Cochlear Limited 2.24B
Sonic Healthcare Limited 8.97B
Ramsay Health Care Limited 16.66B
Telix Pharmaceuticals Limited 645.68M
Revenue Rankings

Mesoblast News

More News